$RIGL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in RIGEL PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in RIGEL PHARMACEUTICALS INC. Get notifications about new insider transactions in RIGEL PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.25 | 7,821 | 166,196 | 490,774 | 498.6 K to 490.8 K (-1.57 %) |
Apr 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.25 | 777 | 16,512 | 10,433 | 11.2 K to 10.4 K (-6.93 %) |
Apr 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.25 | 34,023 | 723,002 | 456,751 | 490.8 K to 456.8 K (-6.93 %) |
Apr 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.25 | 179 | 3,804 | 11,210 | 11.4 K to 11.2 K (-1.57 %) |
Apr 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.25 | 7,821 | 166,196 | 490,774 | 498.6 K to 490.8 K (-1.57 %) |
Apr 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.26 | 161 | 3,422 | 11,389 | 11.6 K to 11.4 K (-1.39 %) |
Apr 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.26 | 7,039 | 149,616 | 498,595 | 505.6 K to 498.6 K (-1.39 %) |
Apr 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.26 | 38 | 808 | 11,550 | 11.6 K to 11.6 K (-0.33 %) |
Apr 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.26 | 1,662 | 35,334 | 505,634 | 507.3 K to 505.6 K (-0.33 %) |
Apr 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.26 | 161 | 3,422 | 11,389 | 11.6 K to 11.4 K (-1.39 %) |
Apr 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.26 | 7,039 | 149,616 | 498,595 | 505.6 K to 498.6 K (-1.39 %) |
Apr 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.26 | 38 | 808 | 11,550 | 11.6 K to 11.6 K (-0.33 %) |
Apr 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.26 | 1,662 | 35,334 | 505,634 | 507.3 K to 505.6 K (-0.33 %) |
Apr 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.32 | 293 | 6,247 | 11,588 | 11.9 K to 11.6 K (-2.47 %) |
Apr 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.32 | 12,807 | 273,039 | 507,296 | 520.1 K to 507.3 K (-2.46 %) |
Apr 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.32 | 293 | 6,247 | 11,588 | 11.9 K to 11.6 K (-2.47 %) |
Apr 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.32 | 12,807 | 273,039 | 507,296 | 520.1 K to 507.3 K (-2.46 %) |
Apr 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.25 | 42 | 893 | 11,881 | 11.9 K to 11.9 K (-0.35 %) |
Apr 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.25 | 1,858 | 39,483 | 520,103 | 522 K to 520.1 K (-0.36 %) |
Apr 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.27 | 154 | 3,275 | 11,923 | 12.1 K to 11.9 K (-1.28 %) |
Apr 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.27 | 6,746 | 143,472 | 521,961 | 528.7 K to 522 K (-1.28 %) |
Apr 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.25 | 42 | 893 | 11,881 | 11.9 K to 11.9 K (-0.35 %) |
Apr 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.25 | 1,858 | 39,483 | 520,103 | 522 K to 520.1 K (-0.36 %) |
Apr 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.27 | 154 | 3,275 | 11,923 | 12.1 K to 11.9 K (-1.28 %) |
Apr 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.27 | 6,746 | 143,472 | 521,961 | 528.7 K to 522 K (-1.28 %) |
Apr 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 20.78 | 133,698 | 2,778,605 | 3,675,571 | 3.8 M to 3.7 M (-3.51 %) |
Apr 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 20.30 | 25,000 | 507,500 | 3,809,269 | 3.8 M to 3.8 M (-0.65 %) |
Apr 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 20.78 | 133,698 | 2,778,605 | 3,675,571 | 3.8 M to 3.7 M (-3.51 %) |
Apr 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 20.30 | 25,000 | 507,500 | 3,809,269 | 3.8 M to 3.8 M (-0.65 %) |
Apr 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 20.78 | 133,698 | 2,778,605 | 3,675,571 | 3.8 M to 3.7 M (-3.51 %) |
Apr 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 20.30 | 25,000 | 507,500 | 3,809,269 | 3.8 M to 3.8 M (-0.65 %) |
Apr 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 20.78 | 133,698 | 2,778,605 | 3,675,571 | 3.8 M to 3.7 M (-3.51 %) |
Apr 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 20.30 | 25,000 | 507,500 | 3,809,269 | 3.8 M to 3.8 M (-0.65 %) |
Apr 13 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 19.80 | 400 | 7,920 | 3,834,269 | 3.8 M to 3.8 M (-0.01 %) |
Apr 13 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 19.93 | 315,902 | 6,295,927 | 3,834,669 | 4.2 M to 3.8 M (-7.61 %) |
Apr 13 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 19.80 | 400 | 7,920 | 3,834,269 | 3.8 M to 3.8 M (-0.01 %) |
Apr 13 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 19.93 | 315,902 | 6,295,927 | 3,834,669 | 4.2 M to 3.8 M (-7.61 %) |
Apr 13 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 19.80 | 400 | 7,920 | 3,834,269 | 3.8 M to 3.8 M (-0.01 %) |
Apr 13 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 19.93 | 315,902 | 6,295,927 | 3,834,669 | 4.2 M to 3.8 M (-7.61 %) |
Apr 13 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 19.80 | 400 | 7,920 | 3,834,269 | 3.8 M to 3.8 M (-0.01 %) |
Apr 13 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 19.93 | 315,902 | 6,295,927 | 3,834,669 | 4.2 M to 3.8 M (-7.61 %) |
Apr 08 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.00 | 1,347 | 28,288 | 12,077 | 13.4 K to 12.1 K (-10.03 %) |
Apr 08 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.00 | 58,953 | 1,238,054 | 528,707 | 587.7 K to 528.7 K (-10.03 %) |
Apr 08 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.00 | 1,347 | 28,288 | 12,077 | 13.4 K to 12.1 K (-10.03 %) |
Apr 08 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.00 | 58,953 | 1,238,054 | 528,707 | 587.7 K to 528.7 K (-10.03 %) |
Apr 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.00 | 217 | 4,557 | 13,424 | 13.6 K to 13.4 K (-1.59 %) |
Apr 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.00 | 9,483 | 199,143 | 587,660 | 597.1 K to 587.7 K (-1.59 %) |
Apr 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 22.95 | 27 | 620 | 13,641 | 13.7 K to 13.6 K (-0.20 %) |
Apr 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 22.95 | 1,173 | 26,920 | 597,143 | 598.3 K to 597.1 K (-0.20 %) |
Apr 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.00 | 217 | 4,557 | 13,424 | 13.6 K to 13.4 K (-1.59 %) |
Apr 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.00 | 9,483 | 199,143 | 587,660 | 597.1 K to 587.7 K (-1.59 %) |
Apr 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 22.95 | 27 | 620 | 13,641 | 13.7 K to 13.6 K (-0.20 %) |
Apr 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 22.95 | 1,173 | 26,920 | 597,143 | 598.3 K to 597.1 K (-0.20 %) |
Apr 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Buy | J | 0.00 | 2,294 | 0 | 3,976 | 1.7 K to 4 K (+136.39 %) |
Apr 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Sell | J | 0.00 | 497,475 | 0 | 1,405,989 | 1.9 M to 1.4 M (-26.14 %) |
Apr 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Sell | S | 22.76 | 2,524 | 57,457 | 0 | 2.5 K to 0 (-100.00 %) |
Mar 26 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 20.00 | 167 | 3,340 | 13,668 | 13.8 K to 13.7 K (-1.21 %) |
Mar 26 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 20.00 | 7,320 | 146,400 | 598,316 | 605.6 K to 598.3 K (-1.21 %) |
Mar 26 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.00 | 167 | 3,340 | 13,668 | 13.8 K to 13.7 K (-1.21 %) |
Mar 26 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.00 | 7,320 | 146,400 | 598,316 | 605.6 K to 598.3 K (-1.21 %) |
Mar 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 20.00 | 17,334 | 346,680 | 4,150,571 | 4.2 M to 4.2 M (-0.42 %) |
Mar 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 20.00 | 17,334 | 346,680 | 4,150,571 | 4.2 M to 4.2 M (-0.42 %) |
Mar 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 20.00 | 17,334 | 346,680 | 4,150,571 | 4.2 M to 4.2 M (-0.42 %) |
Mar 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 20.00 | 17,334 | 346,680 | 4,150,571 | 4.2 M to 4.2 M (-0.42 %) |
Mar 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 20.00 | 17,334 | 346,680 | 4,150,571 | 4.2 M to 4.2 M (-0.42 %) |
Mar 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 20.00 | 17,334 | 346,680 | 4,150,571 | 4.2 M to 4.2 M (-0.42 %) |
Feb 26 2004 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Option Exercise | M | 5.76 | 260,416 | 1,499,996 | 0 | |
Feb 26 2004 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Payment of Exercise | F | 23.55 | 63,689 | 1,499,876 | 1,903,453 | 2 M to 1.9 M (-3.24 %) |
Feb 26 2004 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Buy | M | 5.76 | 260,416 | 1,499,996 | 1,967,141 | 1.7 M to 2 M (+15.26 %) |
Feb 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER HEALTHCARE IV LP | 10% Owner | Sell | S | 18.80 | 396 | 7,445 | 6,180 | 6.6 K to 6.2 K (-6.02 %) |
Feb 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER HEALTHCARE IV LP | 10% Owner | Sell | S | 18.80 | 78,040 | 1,467,152 | 1,217,467 | 1.3 M to 1.2 M (-6.02 %) |
Feb 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 20.00 | 172,373 | 3,447,460 | 4,167,905 | 4.3 M to 4.2 M (-3.97 %) |
Feb 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 20.00 | 172,373 | 3,447,460 | 4,167,905 | 4.3 M to 4.2 M (-3.97 %) |
Feb 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 20.00 | 172,373 | 3,447,460 | 4,167,905 | 4.3 M to 4.2 M (-3.97 %) |
Feb 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 20.00 | 172,373 | 3,447,460 | 4,350,516 | 4.5 M to 4.4 M (-3.81 %) |
Feb 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOEQUITIES MASTER FUND LP | 10% Owner | Sell | S | 20.00 | 172,373 | 3,447,460 | 4,350,516 | 4.5 M to 4.4 M (-3.81 %) |
Feb 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOEQUITIES MASTER FUND LP | 10% Owner | Sell | S | 20.00 | 172,373 | 3,447,460 | 4,350,516 | 4.5 M to 4.4 M (-3.81 %) |
Feb 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 20.00 | 2,496 | 49,920 | 13,003 | 15.5 K to 13 K (-16.10 %) |
Feb 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 20.00 | 109,200 | 2,184,000 | 569,236 | 678.4 K to 569.2 K (-16.10 %) |
Feb 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.00 | 2,496 | 49,920 | 13,003 | 15.5 K to 13 K (-16.10 %) |
Feb 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.00 | 109,200 | 2,184,000 | 569,236 | 678.4 K to 569.2 K (-16.10 %) |
Feb 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.00 | 2,496 | 49,920 | 13,003 | 15.5 K to 13 K (-16.10 %) |
Feb 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.00 | 109,200 | 2,184,000 | 569,236 | 678.4 K to 569.2 K (-16.10 %) |
Feb 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.00 | 2,496 | 49,920 | 13,003 | 15.5 K to 13 K (-16.10 %) |
Feb 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.00 | 109,200 | 2,184,000 | 569,236 | 678.4 K to 569.2 K (-16.10 %) |
Jan 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 24.30 | 7,628 | 185,360 | 7,628 | |
Jan 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 23.00 | 8,333 | 191,659 | 8,333 | |
Jan 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | RENTON HOLLINGS | Director | Option Exercise | A | 23.00 | 13,333 | 306,659 | 13,333 | |
Jan 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 24.30 | 9,445 | 229,514 | 9,445 | |
Jan 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 23.00 | 8,333 | 191,659 | 8,333 | |
Jan 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Option Exercise | A | 23.00 | 8,333 | 191,659 | 8,333 | |
Jan 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Option Exercise | A | 23.00 | 8,333 | 191,659 | 8,333 |